{"id":"W2126275851","doi":"10.1056/nejmoa072113","title":"Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer","year":2007,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":3053,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Sanofi; Genentech; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Medicine; Paclitaxel; Bevacizumab; Metastatic breast cancer; Oncology; Internal medicine; Breast cancer; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001574216,0.0008752925,0.002115772,0.0005222843,0.0002895791,0.0007648268,0.0006381089,0.001013899,0.004646091],"category_scores_gemma":[0.001816963,0.0003935191,0.0009385152,0.0004347333,0.0006363813,0.0006948933,0.0002825271,0.002110567,0.0006539386],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009276784,"about_ca_system_score_gemma":0.001077468,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007201209,"about_ca_topic_score_gemma":0.001895517,"domain_scores_codex":[0.9993551,0.0003605559,0.00004740468,0.0000976473,0.00006560365,0.00007358845],"domain_scores_gemma":[0.9989336,0.0004029174,0.0003029205,0.00003426036,0.00004189452,0.0002843203],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9511638,0.006444362,0.0008408267,0.0005137271,0.0007354359,0.00004695964,0.00002690757,0.0006354363,0.002432522,0.0001053496,0.0007721693,0.03628256],"study_design_scores_gemma":[0.8474844,0.146176,0.002749514,0.00005689994,0.0006360215,0.00009241553,0.00001173052,0.0009261334,0.0007686978,0.0002056106,0.0008799249,0.0000127195],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9883987,0.006642734,0.0004249552,0.000747113,0.0005360332,0.001359482,0.0003355617,0.00008012803,0.001475331],"genre_scores_gemma":[0.9904026,0.003360012,0.001321486,0.0009473998,0.0006620555,0.001605047,0.0005491321,0.00001541614,0.001136857],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004646091,"threshold_uncertainty_score":0.01554275,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05956126811358634,"score_gpt":0.3994659375435287,"score_spread":0.3399046694299423,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}